Correlation Between Virax Biolabs and Scisparc

Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Scisparc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Scisparc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virax Biolabs Group and Scisparc, you can compare the effects of market volatilities on Virax Biolabs and Scisparc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Scisparc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Scisparc.

Diversification Opportunities for Virax Biolabs and Scisparc

0.11

Correlation Coefficient

Virax Biolabs  Scisparc

Average diversification

The 3 months correlation between Virax and Scisparc is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Scisparc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scisparc and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Scisparc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scisparc has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Scisparc go up and down completely randomly.

Pair Corralation between Virax Biolabs and Scisparc

Given the investment horizon of 90 days Virax Biolabs is expected to generate 18.58 times less return on investment than Scisparc. But when comparing it to its historical volatility, Virax Biolabs Group is 1.76 times less risky than Scisparc. It trades about 0.01 of its potential returns per unit of risk. Scisparc is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  575.00  in Scisparc on April 30, 2025 and sell it today you would earn a total of  157.00  from holding Scisparc or generate 27.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Virax Biolabs Group  vs.  Scisparc

Virax Biolabs Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Virax Biolabs is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Scisparc

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Scisparc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Scisparc exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Virax Biolabs and Scisparc

The main advantage of trading using opposite Virax Biolabs and Scisparc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Scisparc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scisparc will offset losses from the drop in Scisparc's long position.

The idea behind Virax Biolabs Group and Scisparc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.